Pomerantz LLP is investigating claims on behalf of investors of INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ: INCR). Such investors are advised to contact Robert S. Willoughby at firstname.lastname@example.org or 888-476-6529, ext. 9980.
The investigation concerns whether INC Research and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On August 1, 2017, INC Research and inVentiv Health, Inc. ("inVentiv Health") announced the completion of a merger between the two companies. On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health. The Company's combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses.
On this news, INC Research's share price fell $16.35, or 28.43%, to close at $41.15 on November 9, 2017.